Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Net Cash Flow (2017 - 2025)

Q32 Bio (QTTB) has 9 years of Net Cash Flow data on record, last reported at -$742000.0 in Q4 2025.

  • For Q4 2025, Net Cash Flow rose 93.32% year-over-year to -$742000.0; the TTM value through Dec 2025 reached -$29.7 million, down 162.66%, while the annual FY2025 figure was -$29.7 million, 162.66% down from the prior year.
  • Net Cash Flow reached -$742000.0 in Q4 2025 per QTTB's latest filing, up from -$5.8 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $138.1 million in Q1 2022 and bottomed at -$133.0 million in Q3 2022.
  • Average Net Cash Flow over 5 years is -$9.3 million, with a median of -$10.6 million recorded in 2023.
  • Peak YoY movement for Net Cash Flow: plummeted 707.0% in 2022, then surged 779.9% in 2024.
  • A 5-year view of Net Cash Flow shows it stood at $13.2 million in 2021, then tumbled by 169.35% to -$9.2 million in 2022, then dropped by 15.94% to -$10.6 million in 2023, then fell by 4.46% to -$11.1 million in 2024, then soared by 93.32% to -$742000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Net Cash Flow were -$742000.0 in Q4 2025, -$5.8 million in Q3 2025, and -$10.7 million in Q2 2025.